A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

Clinical trial NCT06008366 · UNKNOWN

Trial details

NCT number: NCT06008366
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-09-05
Primary completion: 2025-08-30
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.